Video-assisted thoracoscopic lobectomy: which patients require postoperative physiotherapy?

Agostini, Paula; Lugg, Sebastian T; Adams, Kerry; Smith, Tom; Kalkat, Maninder; Rajesh, P.; Steyn, RS; Naidu, Babu; Rushton, Alison; Bishay, Ehab

doi:10.1016/j.physio.2019.01.001

Cited by 7 publications

(6 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although the invasion was minimal after VATS, we have thought that the physical function and walking ability of the patients decreased after VATS because their physical activity decreased due to pain and thoracic drain placement. As with postoperative patients with other diseases, the importance of an early increase in physical activity has been shown from the study with VATS patients [7]. This study has confirmed the previous study, and we, therefore, consider the importance of early rehabilitation.…”

Section: Discussionsupporting

confidence: 89%

“…Regarding rehabilitation for VATS patients, enhanced recovery program including rehabilitation has been shown to have no effect on cardiopulmonary complications, 30-and 90-day mortality, length of stay, and readmissions [6]. On the other hand, other studies have shown that most of VATS lobectomy patients demonstrated conditions potentially amenable to rehabilitation [7]. Therefore, it has been reported that all patients need to receive routine postoperative rehabilitation evaluations to identify problems early and correctly [7].…”

Section: Introductionmentioning

confidence: 99%

“…On the other hand, other studies have shown that most of VATS lobectomy patients demonstrated conditions potentially amenable to rehabilitation [7]. Therefore, it has been reported that all patients need to receive routine postoperative rehabilitation evaluations to identify problems early and correctly [7].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Short-Term Impact of Video-Assisted Thoracoscopic Surgery on Lung Function, Physical Function, and Quality of Life

et al. 2021

View full text Add to dashboard Cite

Background: Video-assisted thoracoscopic surgery (VATS) has been increasingly used as an approach for lung lobectomy. However, the recovery of respiratory and physical function may be insufficient at discharge because the average length of hospital stay is decreasing after surgery. In this study, we investigated the changes in physical function, lung function, and quality of life (QOL) of lung cancer patients after VATS, and factors for QOL were also evaluated. Methods: The subjects of this study were 41 consecutive patients who underwent video-assisted lung lobectomy for lung cancer. Rehabilitation was performed both before and after surgery. Lung function testing, physical function testing (timed up and go test (TUG) and the 30-s chair-stand test (CS-30)), and QOL (EORTC QLQ-C30) were measured before and 1 week after surgery. Results: Postoperative VC recovered to 76.3% ± 15.6% 1 week after surgery. TUG, CS-30, and QOL were significantly worse after surgery (p < 0.05). Lung function and physical function were found to affect QOL. Postoperative complications included pneumonia in 1 patient. There were no patients who discontinued rehabilitation. Conclusion: Our rehabilitation program was safe and useful for patients after VATS.

show abstract

Section: Discussionsupporting

confidence: 89%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Short-Term Impact of Video-Assisted Thoracoscopic Surgery on Lung Function, Physical Function, and Quality of Life

et al. 2021

View full text Add to dashboard Cite

show abstract

“…However, for many anesthesiologists and thoracic surgeons, postoperative pain management, especially early postoperative pain, remains a source of concern [ 3 ]. Postoperative pain after VATLS might result in several pulmonary complications, such as atelectasis and hypercapnia, as well as lung infection, which can affect the quality of recovery(QoR) [ 4 , 5 ].…”

Section: Introductionmentioning

confidence: 99%

Effect of erector spinae plane block with different doses of dexmedetomidine as adjuvant for ropivacaine on the postoperative quality of recovery after video-assisted thoracoscopic lobectomy surgery: a randomized controlled trial

Guo,

Wang,

Jiang

et al. 2023

BMC Anesthesiol

View full text Add to dashboard Cite

Background Erector spinae plane block (ESPB) improves postoperative analgesia and significantly enhances the quality of recovery (QoR) after video-assisted thoracoscopic lobectomy surgery (VATLS). However, it is not known whether the use of dexmedetomidine (Dex) as an adjunct for ropivacaine to ESPB affects the QoR after VATLS. The purpose of this study was to explore the effects of different Dex dosages as an adjunct for ropivacaine in combination with ultrasound-guided ESPB on the quality of postoperative recovery in patients with VATLS. Methods In this single-center, double-blind, randomized study, 120 patients between the ages of 18 and 65 who were scheduled for VATLS from december 2021 and october 2022 in our hospital under general anesthesia were randomly divided into three groups: ultrasound-guided ESPB with 30 mL of 0.5% ropivacaine (Group R), ultrasound-guided ESPB 0.5% ropivacaine plus 0.5 µg/kg Dex (Group RD1), and ultrasound-guided ESPB 0.5% ropivacaine plus 1.0 µg/kg Dex (Group RD2), ultrasound-guided ESPB was administrated at the T5 vertebral level before surgery. The primary outcome was the QoR-15 score 24 h after the surgery. The secondary outcomes included the QoR-15 scores at 12 h, 48 h, and 72 h after the operation, visual analogue scale (VAS) scores at 8 h, 12 h, 24 h, and 48 h after surgery, cumulative flurbiprofen consumption, postoperative nausea and vomiting (PONV), postoperative bradycardia, and hypotension. Results The QoR-15 scores were higher in group RD2 than the R and RD1 groups on postoperative day 1 (P < 0.05), in addition, no significant difference was found in the QoR-15 scores between groups R and RD1 on postoperative day 1. The VAS scores were significantly lower in group RD2 than in groups RD1 and group R 12–24 h after surgery (P < 0.05). No significant differences were observed in the QoR-15 and VAS scores at 48 and 72 h after surgery between the three groups. The cumulative flurbiprofen consumption was markedly reduced during the 72 h after surgery in the RD2 group (P < 0.05). The incidence of postoperative nausea and vomiting was lower in the RD2 group (P < 0.05). Conclusions The combination of 1 µg/kg dexmedetomidine as an adjunct with 0.5% ropivacaine 30 ml for erector spinae plane block significantly improved the postoperative quality of recovery and provided better postoperative analgesia on postoperative day 1 in patients undergoing Video-assisted thoracoscopic lobectomy surgery. However, dexmedetomidine (1 µg/kg) as an adjunct for ropivacaine combined with erector spinae plane block did not enhance the postoperative quality of recovery at 48 and 72 h postoperatively. Trial registry number The number of this clinical trial registry is ChiCTR2100053230, date of registration: 16/11/ 2021)

show abstract

“…However, most patients experience a variety of complications, such as bleeding, infections, postoperative pain and early postoperative cognitive dysfunction (EPPNCD). [ 11 – 14 ] Thus, it is very important to choose an effective analgesia with fewer complications, especially for EPPNCD.…”

Section: Introductionmentioning

confidence: 99%

Dexmedetomidine for early postoperative cognitive dysfunction after video-assisted thoracoscopic lobectomy in elderly male patients with lung cancer

Shi

et al. 2020

Medicine

View full text Add to dashboard Cite

This retrospective study explored the efficacy and safety of dexmedetomidine in treating early postoperative cognitive dysfunction (EPPNCD) after video-assisted thoracoscopic lobectomy (VATL) in elderly male patients with lung cancer (LC). This study included a total of 80 elderly male patients with LC who received VATL. All of them were equally assigned to a treatment group and a control group, with 40 patients each group. The primary outcome included cognitive dysfunction, as evaluated by mini-mental state examination scale. The secondary outcomes consisted of incidence of EPPNCD, lung function (as measured by forced vital capacity, forced expiratory volume in 1 second, peak expiratory flow, and maximal voluntary ventilation), and adverse events. All outcome data were analyzed before and 3 days after surgery. After surgery, all patients in the treatment group exerted better efficacy in mini-mental state examination scale ( P < .01) and incidence of EPPNCD ( P = .03), than patients in the control group. However, no significant differences were detected in forced vital capacity ( P = .65), forced expiratory volume in 1 second ( P = .50), peak expiratory flow ( P = .73), and maximal voluntary ventilation ( P = .27) between 2 groups. In addition, there is similar safety profile between 2 groups. The findings of this study showed that dexmedetomidine may benefit EPPNCD after VATL in elderly male patients with LC. Future studies are needed to warrant the present conclusions.

show abstract

Video-assisted thoracoscopic lobectomy: which patients require postoperative physiotherapy?

Cited by 7 publications

References 36 publications

Short-Term Impact of Video-Assisted Thoracoscopic Surgery on Lung Function, Physical Function, and Quality of Life

Short-Term Impact of Video-Assisted Thoracoscopic Surgery on Lung Function, Physical Function, and Quality of Life

Effect of erector spinae plane block with different doses of dexmedetomidine as adjuvant for ropivacaine on the postoperative quality of recovery after video-assisted thoracoscopic lobectomy surgery: a randomized controlled trial

Dexmedetomidine for early postoperative cognitive dysfunction after video-assisted thoracoscopic lobectomy in elderly male patients with lung cancer

Contact Info

Product

Resources

About